Metastatic Mediastinal Germ-Cell Tumor and Concurrent COVID-19: When Chemotherapy Is Not Deferrable

Oncologist. 2021 Feb;26(2):e347-e349. doi: 10.1002/onco.13647. Epub 2021 Jan 9.

Abstract

This letter to the editor describes the case of a patient with mediastinal germ cell tumor who developed COVID‐19 at the end of the first cycle of chemotherapy and continues the discussion on whether it is best to continue or delay administration of chemotherapy with an active COVID‐19 infection.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Mediastinal Neoplasms* / complications
  • Mediastinal Neoplasms* / drug therapy
  • Neoplasms, Germ Cell and Embryonal* / complications
  • Neoplasms, Germ Cell and Embryonal* / drug therapy
  • Pandemics
  • SARS-CoV-2